FREE subscriptions for doctors and students... click here
You have 3 more open access pages.
Patients with a clinical diagnosis of carotid sinus syndrome and two or more
episodes of syncope should be given a dual chamber pacemaker (1)
- will abolish syncope in 90% of patients (1)
- American College of Cardiology/American Heart Association/Heart Rhythm
Society clinical practice guidelines consider permanent pacing therapy
to be a class I indication (ie, general agreement exists that the therapy
is effective and useful) in patients with recurrent syncope caused by
carotid sinus stimulation in the absence of any drug that depresses the
sinus node or atrioventricular conduction
- EBM 1999; 4 (6): 170.
- Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes
LS, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac
Rhythm Abnormalities: a report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines (Writing Committee to
Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac
Pacemakers and Antiarrhythmia Devices) developed in collaboration with the
American Association for Thoracic Surgery and Society of Thoracic Surgeons.
J Am Coll Cardiol. May 27 2008;51(21):e1-62
Last reviewed 01/2018